In the pharmaceutical industry, ensuring the safety and efficacy of drug delivery systems is paramount. This is particularly true for nasal spray pumps, a critical delivery method for many therapeutic agents. A key component of this assurance process is the Extractable Report, an extensive analysis designed to identify potential contaminants that could migrate from the packaging material into the product.

1. Understanding the Extractable Report

An Extractable Report identifies potential chemical entities that might migrate from the drug's packaging or delivery system under extreme conditions. These entities, known as extractables, can be organic or inorganic compounds and are assessed through a series of laboratory tests. The report provides a detailed account of these compounds, ensuring that any potential risk to patient safety is mitigated.

2. Operational Steps

The process of generating an Extractable Report involves several key steps:

• Sample Preparation: Packaging components are exposed to solvents under controlled conditions that simulate or exaggerate real-world scenarios.
• Analytical Testing: Advanced analytical methods such as HPLC, GC-MS, and ICP-MS are employed to identify and quantify the extractables.
• Data Analysis: The results are carefully analyzed to identify potential risks, considering the toxicological profile of the detected compounds.
• Risk Assessment: A comprehensive risk assessment is conducted to understand the potential impact of the identified extractables on patient safety and product stability.
• Recommendations: Based on the findings, recommendations are made regarding the suitability of packaging materials and any necessary modifications to ensure safety.

3. Significance of Parameters

Several critical parameters are considered in an Extractable Report:

• Safety Concern Threshold (SCT): The maximum allowable level of a compound below which there is negligible risk to patient health.
• Analytical Evaluation Threshold (AET): The level at which a compound must be identified and quantified for toxicological assessment.
• Permitted Daily Exposure (PDE): The maximum acceptable intake of extractable compounds, ensuring patient safety over the drug's usage period.

4. Focus on Nasal Spray Pumps

For nasal spray pumps, the Extractable Report focuses on components directly in contact with the drug formulation and those that might indirectly affect it. These typically include:

• Pump housing and mechanism: Materials used in the pump's construction are analyzed for potential extractables that could contaminate the drug.
• Container: The bottle holding the drug formulation is a primary source for potential extractables.
• Seals and gaskets: These components ensure the integrity of the nasal spray pump but can also be sources of chemical migration.
• Actuator and nozzle: Direct contact with the drug formulation makes the actuator and nozzle critical components for analysis.

Conclusion

At BONA Pharma, we understand acutely that an Extractable Report is crucial for ensuring the safety and efficacy of nasal spray pumps. So, we meticulously analyze each component for potential contaminants. This means that our customers, pharmaceutical companies, can guarantee that their products are safe for patient use.

Discover BONA Pharma's nasal spray pumps or browse all the products in BONA's packaging catalog.